Behzad Aghazadeh's Net Worth

-$171 Million

Estimate Recalculated Jul 2, 2024 05:39PM EST

Who is Behzad Aghazadeh?

Behzad Aghazadeh does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, Mirati Therapeutics, Inc., CymaBay Therapeutics, Inc., and Aadi Bioscience, Inc..

SEC CIK

Behzad Aghazadeh's CIK is 0001701815

Past Insider Trading and Trends

2019 was Behzad Aghazadeh's most active year for acquiring shares with 15 total transactions. Behzad Aghazadeh's most active month to acquire stocks was the month of May. 2018 was Behzad Aghazadeh's most active year for disposing of shares, totalling 7 transactions. Behzad Aghazadeh's most active month to dispose stocks was the month of January. 2020 saw Behzad Aghazadeh paying a total of $49,875,000.00 for 1,860,258 shares, this is the most they've acquired in one year. In 2019 Behzad Aghazadeh cashed out on 998,101 shares for a total of $75,148,366.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNOMEDICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-26.26M
—
—
0
Oct 23
Form 4
+27.51%
3.72K
—
—
17.23K
Jun 18
Form 4
+7.14%
1.75M
$28.50
$49,875,000.00
26.25M
May 1
Form 4
∞
100K
—
—
100K
Mar 20
Form 4
+8.89%
2M
$17.50
$35,000,000.00
24.5M
Dec 5
Form 4
—
0
—
—
0
Nov 19
Form 4
+3.49%
1.5M
$13.67
$20,280,000.00
44.5M
Oct 2 - Oct 3
Form 4
+2.48%
1M
$13.50
$13,548,000.00
41.4M
Jun 26 - Jun 28
Form 4
+251.16%
9.67K
—
—
13.52K
Jun 7
Form 4
+4.07%
1.54M
$12.21
$18,743,220.41
39.25M
Jun 3 - Jun 5
Form 4
+2.09%
750K
$15.13
$11,328,750.00
36.68M
May 13 - May 15
Form 4
∞
3.85K
—
—
3.85K
Apr 2
Form 4
+1.14%
200K
$23.39
$4,678,000.00
17.71M
Jun 15
Form 4
+3.39%
575K
$24.00
$13,800,000.00
17.51M
Jun 15
Form 4
+5.45%
875K
$7.00
$6,125,000.00
16.94M
Feb 16
Form 4
+4.33%
1.32M
$10.68
$13,868,250.00
31.95M
Nov 14 - Nov 15
Form 4
+40.54%
4.25M
—
—
14.74M
Aug 24
Form 4
—
0
—
—
0
Aug 21 - Aug 23
Form 4
—
0
—
—
0
Jul 3
Form 4
—
0
—
—
0
May 4
Form 3
—
0
—
—
0
No matching records found

Mirati Therapeutics, Inc. (MRTX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.62%
-62.50K
$101.88
-$6,367,500.00
3.8M
Jul 23
Form 4
-3.07%
-248.78K
$74.93
-$18,643,006.80
7.85M
Mar 18 - Mar 20
Form 4
-14.31%
-686.82K
$73.00
-$50,137,860.00
4.11M
Feb 20
Form 4
+9.09%
400K
$38.85
$15,540,000.00
4.8M
Jun 11
Form 4
+8.52%
687.5K
$10.43
$8,744,750.00
8.76M
Nov 16
Form 3
—
0
—
—
0
No matching records found

CymaBay Therapeutics, Inc. (CBAY) Snapshot price: $24.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 12 - Sep 13
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Nov 22
Form 3
—
0
—
—
0
No matching records found

Aadi Bioscience, Inc. (AADI) Snapshot price: $1.755

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 15
Form 4
+56.97%
1.26M
$12.50
$15,750,000.00
3.47M
Sep 22
Form 4
—
0
—
—
0
Jun 15
Form 4
+637.25%
1.91M
$13.08
$24,999,980.90
2.21M
Aug 26 - Aug 27
Form 3
—
0
—
—
0
No matching records found